Tewari Anurag, Dhawan Ira, Mahendru Vidhi, Katyal Sunil, Singh Avtar, Narula Navneet
Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
J Anaesthesiol Clin Pharmacol. 2014 Jul;30(3):340-4. doi: 10.4103/0970-9185.137264.
Perioperative shivering, in geriatric patients undergoing urological surgery under central neuraxial blockade is a common complication. Prophylactic measures to reduce shivering are quintessential to decrease the morbidity and mortality. Believing that oral formulation will bring down the cost of treatment, we decided to compare the efficacy of oral clonidine and tramadol, as premedication, in prevention of shivering in patients undergoing transurethral resection of prostate (TURP) under spinal anesthesia in a prospective and double-blind manner.
The patients were randomly allocated into three groups (40 patients each). Group I received oral clonidine 150 μg, Group II received oral tramadol 50 mg, while Group III received a placebo. Number of patients having shivering, their grades and duration, hemodynamic changes, and side-effects in the form of sedation were recorded. Data were analyzed using analysis of variance, Student's t-test, Z test as and when appropriate.
In group I and II, 38 patients (95%) and 37 patients (92.5%) did not shiver, respectively. Although in the group III, 24 patients (60%) exhibited no grade of shivering, the shivering was of significantly severe intensity and lasted for a longer duration. No, clinically significant collateral effects were observed in patients who were administered clonidine or tramadol.
Oral clonidine and tramadol were comparable in respect to their effect in decreasing the incidence, intensity, and duration of shivering when used prophylactically in patients who underwent TURP under subarachnoid blockade.
在接受中枢神经阻滞的老年泌尿外科手术患者中,围手术期寒战是一种常见并发症。采取预防措施减少寒战对于降低发病率和死亡率至关重要。鉴于口服制剂会降低治疗成本,我们决定以前瞻性、双盲方式比较口服可乐定和曲马多作为术前用药预防蛛网膜下腔麻醉下行经尿道前列腺切除术(TURP)患者寒战的疗效。
将患者随机分为三组(每组40例)。第一组口服可乐定150μg,第二组口服曲马多50mg,第三组服用安慰剂。记录发生寒战的患者数量、寒战分级及持续时间、血流动力学变化以及镇静形式的副作用。在适当的时候使用方差分析、学生t检验、Z检验对数据进行分析。
第一组和第二组分别有38例患者(95%)和37例患者(92.5%)未发生寒战。虽然第三组有24例患者(60%)未出现寒战分级,但寒战程度明显更严重且持续时间更长。给予可乐定或曲马多的患者未观察到具有临床意义的副作用。
在蛛网膜下腔阻滞下行TURP的患者中预防性使用时,口服可乐定和曲马多在降低寒战发生率、严重程度和持续时间方面效果相当。